20th sep announcement, page-2

If they are getting anything like 20 percent biochemical availability of oral insulin, you had better bet that that is significant.

also, they have made statements that differentiate their approach from that of others (see EMIS) in a way that makes the MBP system look even better.

My only concern is that they have this patent protected.

That, and all the usual concerns about management.